1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Diagnosis and Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Lung Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-Small Cell Lung Cancer
1.4.3 Small Cell Lung Cancer
1.5 Market by Application
1.5.1 Global Lung Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Diagnosis and Therapeutics Market Perspective (2015-2026)
2.2 Global Lung Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Lung Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lung Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lung Cancer Diagnosis and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Lung Cancer Diagnosis and Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnosis and Therapeutics Players by Market Size
3.1.1 Global Top Lung Cancer Diagnosis and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Lung Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.2.1 Global Lung Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnosis and Therapeutics Revenue in 2019
3.3 Lung Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.4 Key Players Lung Cancer Diagnosis and Therapeutics Product Solution and Service
3.5 Date of Enter into Lung Cancer Diagnosis and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lung Cancer Diagnosis and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
5.2 Global Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
6.2 Lung Cancer Diagnosis and Therapeutics Key Players in North America (2019-2020)
6.3 North America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
6.4 North America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
7.2 Lung Cancer Diagnosis and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
8.2 Lung Cancer Diagnosis and Therapeutics Key Players in China (2019-2020)
8.3 China Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
8.4 China Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
9.2 Lung Cancer Diagnosis and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
10.2 Lung Cancer Diagnosis and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
11.2 Lung Cancer Diagnosis and Therapeutics Key Players in India (2019-2020)
11.3 India Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
11.4 India Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020)
12.2 Lung Cancer Diagnosis and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Introduction
13.2.4 Eli Lilly Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Lung Cancer Diagnosis and Therapeutics Introduction
13.3.4 Sanofi Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 ArQule
13.4.1 ArQule Company Details
13.4.2 ArQule Business Overview
13.4.3 ArQule Lung Cancer Diagnosis and Therapeutics Introduction
13.4.4 ArQule Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.4.5 ArQule Recent Development
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Details
13.5.2 Daiichi Sankyo Business Overview
13.5.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Introduction
13.5.4 Daiichi Sankyo Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.5.5 Daiichi Sankyo Recent Development
13.6 Celgene
13.6.1 Celgene Company Details
13.6.2 Celgene Business Overview
13.6.3 Celgene Lung Cancer Diagnosis and Therapeutics Introduction
13.6.4 Celgene Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.6.5 Celgene Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Lung Cancer Diagnosis and Therapeutics Introduction
13.7.4 Merck Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview
13.8.3 Pfizer Lung Cancer Diagnosis and Therapeutics Introduction
13.8.4 Pfizer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.8.5 Pfizer Recent Development
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Details
13.9.2 Boehringer Ingelheim Business Overview
13.9.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Introduction
13.9.4 Boehringer Ingelheim Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.9.5 Boehringer Ingelheim Recent Development
13.10 Roche
13.10.1 Roche Company Details
13.10.2 Roche Business Overview
13.10.3 Roche Lung Cancer Diagnosis and Therapeutics Introduction
13.10.4 Roche Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
13.10.5 Roche Recent Development
13.11 Genentech
10.11.1 Genentech Company Details
10.11.2 Genentech Business Overview
10.11.3 Genentech Lung Cancer Diagnosis and Therapeutics Introduction
10.11.4 Genentech Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.11.5 Genentech Recent Development
13.12 GSK
10.12.1 GSK Company Details
10.12.2 GSK Business Overview
10.12.3 GSK Lung Cancer Diagnosis and Therapeutics Introduction
10.12.4 GSK Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.12.5 GSK Recent Development
13.13 Pharmacyclics
10.13.1 Pharmacyclics Company Details
10.13.2 Pharmacyclics Business Overview
10.13.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Introduction
10.13.4 Pharmacyclics Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.13.5 Pharmacyclics Recent Development
13.14 Novartis
10.14.1 Novartis Company Details
10.14.2 Novartis Business Overview
10.14.3 Novartis Lung Cancer Diagnosis and Therapeutics Introduction
10.14.4 Novartis Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.14.5 Novartis Recent Development
13.15 Bayer
10.15.1 Bayer Company Details
10.15.2 Bayer Business Overview
10.15.3 Bayer Lung Cancer Diagnosis and Therapeutics Introduction
10.15.4 Bayer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.15.5 Bayer Recent Development
13.16 Bristol-Myers Squibb
10.16.1 Bristol-Myers Squibb Company Details
10.16.2 Bristol-Myers Squibb Business Overview
10.16.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Introduction
10.16.4 Bristol-Myers Squibb Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.16.5 Bristol-Myers Squibb Recent Development
13.17 Eisai
10.17.1 Eisai Company Details
10.17.2 Eisai Business Overview
10.17.3 Eisai Lung Cancer Diagnosis and Therapeutics Introduction
10.17.4 Eisai Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.17.5 Eisai Recent Development
13.18 AbbVie
10.18.1 AbbVie Company Details
10.18.2 AbbVie Business Overview
10.18.3 AbbVie Lung Cancer Diagnosis and Therapeutics Introduction
10.18.4 AbbVie Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)
10.18.5 AbbVie Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
AstraZeneca、Eli Lilly、Sanofi、ArQule、Daiichi Sankyo、Celgene、Merck、Pfizer、Boehringer Ingelheim、Roche、Genentech、GSK、Pharmacyclics、Novartis、Bayer、Bristol-Myers Squibb、Eisai、AbbVie
【免責事項】
https://www.globalresearch.jp/disclaimer